PBLD Human

Phenazine Biosynthesis-Like Protein Domain Containing Human Recombinant
Shipped with Ice Packs
In Stock

Description

Tumor-Suppressive Mechanisms

PBLD inhibits oncogenic pathways through:

  • MAPK/NF-κB Pathway Suppression: Reduces phosphorylation of Smad3 and blocks nuclear translocation of NF-κB .

  • Angiogenesis Inhibition:

    MechanismTarget PathwayEffect on HCC
    Stabilizes DUSP6ERK/HIF-1α/VEGF axisReduces VEGF secretion
    Exosomal miR-940 deliveryETS1/VEGFR2 axisSuppresses endothelial cell proliferation

IFN-I Pathway Activation

PBLD enhances antiviral responses via:

  • NF-κB Signaling: Promotes IKKβ phosphorylation and TRIM21 stabilization, amplifying IFN-α/β production .

  • IRF3 Activation: Phosphorylates IRF3 at Ser<sup>385</sup>/Ser<sup>386</sup>, boosting interferon-stimulated genes (ISGs) .

In Vivo Efficacy

  • Pbld<sup>-/-</sup> mice show 3.8-fold higher viral loads than wild-type during vesicular stomatitis virus (VSV) infection .

  • Overexpression reduces herpes simplex virus-1 (HSV-1) replication by 67% in HeLa cells .

Interaction with Cedrelone

The limonoid Cedrelone upregulates PBLD through:

  • Molecular Docking: Binds PBLD at Ser<sup>45</sup> (ΔG = -7.2 kcal/mol) and Phe<sup>16</sup> (ΔG = -6.9 kcal/mol) .

  • Functional Synergy:

    • Cedrelone + PBLD overexpression reduces HCC tumor volume by 58% in xenograft models .

    • Enhances IFN-β production by 4.3-fold during bovine parainfluenza virus 3 (BPIV3) infection .

Therapeutic Implications

  • Cancer Therapy: Low PBLD correlates with advanced HCC stages (HR = 0.364 for OS, P = 0.040) . Cedrelone restores PBLD expression, inducing apoptosis in SW480 colon cancer cells (IC<sub>50</sub> = 8.2 μM) .

  • Antiviral Drug Development: PBLD activators like Cedrelone suppress HSV-1 replication by 89% at 10 μM .

Future Directions

  • Targeting PBLD-TRIM21-IKKβ axis for broad-spectrum antivirals.

  • Biomarker validation in HCC immunotherapy trials.

Product Specs

Introduction
PBLD, a member of the phenazine biosynthesis-like protein (PhzF) family, is the sole representative of this family found in the human genome. Expressed in a wide range of tissues, PBLD plays a role in the MAPK signaling pathway and is involved in numerous fundamental cellular processes. Notably, its expression is elevated in various disease states, including folate deficiency and hypotension.
Description
Recombinant human PBLD, fused with a 20 amino acid His tag at its N-terminus, is produced in E. coli. This yields a single, non-glycosylated polypeptide chain comprising 308 amino acids (residues 1-288) with a molecular weight of 33.9kDa. Purification of PBLD is achieved through proprietary chromatographic techniques.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
The PBLD solution is provided at a concentration of 1 mg/ml and is formulated in a buffer containing 20mM Tris-HCl (pH 8.0), 10% glycerol, 2mM DTT, and 0.1M NaCl.
Stability
For short-term storage (up to 2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. To further enhance long-term stability, the addition of a carrier protein such as HSA or BSA (0.1%) is advised. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 95.0% as determined by SDS-PAGE analysis.
Synonyms
Phenazine biosynthesis-like domain-containing protein, MAWD-binding protein, Unknown protein 32 from 2D-page of liver tissue, PBLD, MAWBP, MAWDBP, FLJ14767, FLJ35507.
Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MKLPIFIADA FTARAFRGNP AAVCLLENEL DEDMHQKIAR EMNLSETAFI RKLHPTDNFA QSSCFGLRWF TPASEVPLCG HATLASAAVL FHKIKNMNST LTFVTLSGEL RARRAEDGIV LDLPLYPAHP QDFHEVEDLI KTAIGNTLVQ DICYSPDTQK LLVRLSDVYN RSFLENLKVN TENLLQVENT GKVKGLILTL KGEPGGQTQA FDFYSRYFAP WVGVAEDPVT GSAHAVLSSY WSQHLGKKEM HAFQCSHRGG ELGISLRPDG RVDIRGGAAV VLEGTLTA.

Q&A

What is PBLD in the context of medical education research?

PBLD (Problem-Based Learning Discussion) is an active-learning pedagogical format that employs a problem-based, student-centered, small-group approach using simulated scenarios. This method avoids the educational assumptions made by conventional teacher-centered lecture-discussion formats. PBLD has been widely implemented across various disciplines globally, including anesthesiology, though its application specifically for teaching research fundamentals has been relatively limited until recent years .

The core methodology involves presenting learners with realistic scenarios that stimulate their existing knowledge while providing meaningful contexts related to their future professional work. This enables active peer teaching-learning in an open communication style, fostering critical thinking and practical application of research concepts .

What is PBLD protein and what role does it play in human immunology?

PBLD (Phenazine Biosynthesis-Like Domain-containing protein) functions as a tumor suppressor and has recently been identified as a critical component in the innate immune response against viral infections. Research has demonstrated that PBLD enhances antiviral innate immunity by promoting the p53–USP4–MAVS signaling axis . The protein has been shown to effectively inhibit the replication of multiple RNA viruses including BEFV, VSV, and H1N1 viruses both in vitro and in vivo, making it a significant molecule of interest in antiviral research .

As a regulatory element in antiviral immune responses, PBLD plays a crucial role in determining viral replication outcomes and represents a potential target for developing therapeutic interventions against RNA virus-mediated infections .

How is PBLD educational methodology implemented in research education settings?

Implementation of PBLD for research education follows a structured approach:

The methodology specifically addresses residents' perceived barriers to research and introduces available institutional resources such as Clinical and Translational Science Institutes (CTSI) .

What experimental design approaches are most effective when studying PBLD protein function?

When studying PBLD protein function, researchers should consider a comprehensive experimental design that incorporates the following methodological elements:

  • In vitro and in vivo models: Utilize both cellular models and animal models to validate findings across different biological systems .

  • Viral challenge assays: Implement controlled viral infections with RNA viruses (e.g., BEFV, VSV, H1N1) to assess PBLD's antiviral properties .

  • Gene expression manipulation: Apply overexpression and knockdown/knockout approaches to elucidate PBLD's functional significance .

  • Signaling pathway analysis: Investigate interactions within the p53–USP4–MAVS signaling axis to determine molecular mechanisms .

  • Controlled variables: Ensure precise control of external and internal factors that could affect experimental outcomes, with random assignment of subjects to experimental groups when applicable .

This experimental approach allows for identification of cause-effect relationships with high accuracy while maintaining standardization for replicability, which enhances study credibility compared to non-standardized scenarios .

How can researchers measure the effectiveness of PBLD educational interventions?

Measuring PBLD effectiveness requires a multi-faceted approach that extends beyond traditional knowledge assessments:

  • Quantitative metrics:

    • Number of resident consultations with research support services (e.g., from 4.7% to 14.0% after PBLD implementation)

    • Increase in new research projects (e.g., 100% increase from 10 to 20 projects as observed in one study)

    • Publication and presentation rates pre- and post-intervention

  • Study design considerations:

    • Retrospective observational studies comparing pre-implementation and post-implementation cohorts

    • Clearly defined cohorts (e.g., 93 residents with PBLD exposure vs. 85 residents without exposure)

    • Longitudinal follow-up to assess sustained impact

  • Implementation assessment:

    • Pre-implementation surveys to identify perceived barriers to research

    • Post-implementation evaluations to assess participant satisfaction and perceived value

    • Qualitative feedback on scenario relevance and discussion quality

Researchers should consider both immediate outcomes (participation in research activities) and long-term impacts (research productivity, career trajectories) when evaluating PBLD effectiveness .

What are the appropriate data analysis methods for PBLD protein expression studies?

Analysis of PBLD protein expression studies requires sophisticated data processing techniques, particularly when working with high-throughput sequencing data:

  • RNA-seq data processing pipeline:

    • Quality control thresholds: Total read counts > 2×10^7, mapping rates > 90%, mean inter-sample correlation coefficients > 0.94

    • Mapping methods: Tools such as Tophat2 against reference genomes (e.g., GRCh37)

    • Expression quantification: Cufflinks with appropriate gene models (e.g., Gencode version 19) to generate FPKM values

  • Expression Quantitative Trait Loci (eQTL) analysis:

    • Integration of genotyping data with expression data

    • Statistical assessment of variant effects on gene expression levels

    • Analysis of cell-type specific effects across immune populations

  • Comparative analysis across cell types:

    • Analysis of PBLD expression patterns across different immune cell populations (CD4+ T cells, CD8+ T cells, B cells, NK cells, and monocytes)

    • Correlation of expression with functional outcomes in different cell types

  • Statistical approaches:

    • Appropriate statistical tests for determining significance (e.g., Fisher's exact test for comparing proportions)

    • Multiple testing corrections when performing genome-wide analyses

These methodologies enable researchers to accurately quantify PBLD expression and correlate it with genetic variation and cellular function .

How can the PBLD educational format be adapted for interdisciplinary research training?

Adapting PBLD for interdisciplinary research training requires thoughtful modifications to the standard format:

  • Scenario construction for interdisciplinary contexts:

    • Develop cases that inherently require multiple disciplinary perspectives

    • Include stakeholders from various fields in scenario development

    • Incorporate methodological approaches from different disciplines

  • Facilitation strategies:

    • Utilize facilitators with diverse disciplinary backgrounds

    • Implement structured discussion techniques that encourage cross-disciplinary dialogue

    • Create balanced participant groups representing various disciplines

  • Resource integration:

    • Introduce research support resources from multiple departments or institutions

    • Highlight interdisciplinary collaboration opportunities and funding mechanisms

    • Demonstrate successful interdisciplinary research examples

  • Evaluation considerations:

    • Assess changes in interdisciplinary collaboration patterns

    • Measure cross-disciplinary knowledge acquisition

    • Evaluate development of communication skills across disciplinary boundaries

This adaptation builds upon the established PBLD format while addressing the unique challenges of interdisciplinary research, including terminology differences, methodological variations, and diverse epistemological approaches .

What are the cutting-edge research questions regarding PBLD protein's role in human antiviral immunity?

Current cutting-edge research on PBLD protein focuses on several sophisticated questions:

  • Signaling pathway integration:

    • How does PBLD precisely modulate the p53–USP4–MAVS signaling axis?

    • What are the protein-protein interaction domains critical for this function?

    • How does PBLD interact with other innate immunity pathways?

  • Viral specificity mechanisms:

    • Why does PBLD show effectiveness against specific RNA viruses?

    • What structural features determine viral susceptibility to PBLD-mediated immunity?

    • How do viruses evolve to evade PBLD-mediated restriction?

  • Therapeutic potential exploration:

    • Can PBLD expression or activity be pharmacologically enhanced?

    • Would targeted delivery of PBLD to specific tissues provide therapeutic benefits?

    • How might PBLD-based therapies compare with existing antiviral approaches?

  • Population variation analysis:

    • How do genetic variants affect PBLD function across human populations?

    • Are there correlations between PBLD polymorphisms and susceptibility to viral diseases?

    • Could eQTL data predict individual responses to PBLD-targeting therapeutics?

These research questions represent the frontier of PBLD investigation, potentially leading to novel antiviral strategies against RNA virus pandemics .

What are the common limitations when studying PBLD educational interventions and how can they be addressed?

Research on PBLD educational interventions faces several methodological challenges:

  • Ecological validity concerns:

    • Challenge: Controlled educational experiments may not reflect real-world learning environments .

    • Solution: Implement PBLD in authentic educational settings while maintaining research rigor through mixed-methods approaches that capture contextual factors.

  • Observer effects:

    • Challenge: The Hawthorne Effect may bias outcomes when participants know they're being observed .

    • Solution: Employ naturalistic observation techniques, longitudinal assessment, and triangulation of multiple data sources.

  • Resource intensiveness:

    • Challenge: PBLD implementation requires significant faculty time and expertise .

    • Solution: Develop sustainable models through faculty development programs, tiered facilitation approaches, and technology-enhanced delivery.

  • Facilitator variability:

    • Challenge: Effectiveness depends heavily on facilitator skills .

    • Solution: Implement standardized facilitator training, provide detailed facilitation guides, and incorporate peer observation and feedback.

  • Outcome attribution:

    • Challenge: Difficult to isolate PBLD effects from other educational influences.

    • Solution: Use controlled comparative designs with clearly defined outcome measures and consistent timing of assessments.

Addressing these limitations enhances the validity of PBLD educational research while acknowledging the inherent complexity of educational interventions .

What challenges exist in isolating and studying the function of PBLD protein in human immunity?

Researchers face several technical and biological challenges when studying PBLD protein function:

  • Cell type heterogeneity:

    • Challenge: PBLD functions may vary across different immune cell populations (CD4+ T cells, CD8+ T cells, B cells, NK cells, and monocytes) .

    • Solution: Implement cell-type specific isolation techniques and single-cell analysis approaches to delineate population-specific functions.

  • Pathway redundancy:

    • Challenge: Immune signaling pathways often have redundant mechanisms that may mask PBLD effects.

    • Solution: Utilize combinatorial knockdown/knockout approaches and pathway-specific reporters to detect subtle functional alterations.

  • Temporal dynamics:

    • Challenge: Antiviral responses occur in temporally coordinated waves that may obscure PBLD's specific role.

    • Solution: Employ time-course experiments with high temporal resolution and synchronized infection models.

  • Translation to in vivo relevance:

    • Challenge: In vitro findings may not accurately predict in vivo functionality.

    • Solution: Validate results using appropriate animal models and ex vivo human samples while controlling for physiological variables.

  • Technical requirements for RNA-seq data quality:

    • Challenge: Maintaining consistent high-quality RNA-seq data (total read counts > 2×10^7, mapping rates > 90%) .

    • Solution: Implement rigorous quality control protocols and standardized sample preparation methods to ensure data reliability.

Addressing these challenges requires sophisticated experimental design and careful interpretation of results within the context of complex human immune responses .

How might PBLD educational methodologies evolve to incorporate emerging research technologies?

The evolution of PBLD educational methodologies will likely incorporate several technological and pedagogical innovations:

  • Virtual and augmented reality integration:

    • Creation of immersive research scenarios that simulate complex experimental settings

    • Real-time visualization of abstract research concepts and data patterns

    • Collaborative virtual environments for geographically dispersed research teams

  • Data science and AI-enhanced learning:

    • Integration of real research datasets for exploration and analysis

    • AI-powered facilitation to supplement human facilitators and provide personalized guidance

    • Simulation of complex research decision points with branching scenarios

  • Remote and asynchronous adaptations:

    • Development of flexible PBLD formats that accommodate diverse learning environments

    • Technology-mediated discussion platforms with structured facilitation tools

    • Just-in-time resource delivery integrated into the learning experience

  • Assessment innovations:

    • Real-time competency tracking through embedded assessment technologies

    • Portfolio-based documentation of research skill development

    • Analytics-driven insights into learner engagement and progression

These evolutions will maintain the core principles of PBLD (problem-based, student-centered, interactive learning) while expanding its accessibility, scalability, and effectiveness for research education .

What are promising future research directions for understanding PBLD protein's therapeutic potential?

Future research on PBLD protein's therapeutic potential should focus on several promising directions:

  • Structure-function relationship elucidation:

    • Detailed structural analysis of PBLD protein domains involved in antiviral activity

    • Identification of minimal functional peptide sequences that retain antiviral properties

    • Structure-guided design of enhanced PBLD variants with optimized activity

  • Systems-level understanding:

    • Comprehensive mapping of PBLD interactions within the innate immune network

    • Multi-omics approaches to characterize the global effects of PBLD modulation

    • Computational modeling of PBLD-dependent antiviral response dynamics

  • Translational development pathways:

    • Screening of compounds that enhance endogenous PBLD expression or activity

    • Development of delivery systems for PBLD-based therapeutics to target tissues

    • Preclinical evaluation in relevant models of viral infection

  • Population genomics approaches:

    • Large-scale analysis of PBLD genetic variants across populations

    • Correlation of expression levels with disease susceptibility using eQTL datasets

    • Identification of individuals who might benefit most from PBLD-targeting therapies

  • Combination therapeutic strategies:

    • Investigation of synergistic effects with existing antiviral agents

    • Exploration of PBLD as an adjuvant to enhance vaccine efficacy

    • Development of multi-target approaches addressing different aspects of viral replication

These research directions could ultimately lead to novel therapeutic strategies against viral infections through enhancement of the innate immune response .

Product Science Overview

Introduction

Phenazine Biosynthesis-Like Protein Domain Containing (PBLD) is a protein encoded by the PBLD gene in humans. This protein is involved in various biological processes and has been studied for its potential roles in disease mechanisms and therapeutic applications.

Gene and Protein Structure

The PBLD gene is located on chromosome 10 and encodes a protein that consists of 255 amino acids . The protein is highly conserved across different species, indicating its essential biological functions . It shares significant sequence similarity with the Arabidopsis enzyme Phzf, which is involved in phenazine biosynthesis .

Biological Functions

PBLD is known to play a role in several cellular processes, including:

  • Maintenance of Gastrointestinal Epithelium: PBLD is involved in maintaining the integrity of the gastrointestinal lining .
  • Negative Regulation of SMAD Protein Signal Transduction: It negatively regulates the SMAD protein signaling pathway, which is crucial for various cellular processes .
  • Negative Regulation of Transforming Growth Factor Beta (TGF-β) Receptor Signaling Pathway: PBLD also negatively regulates the TGF-β receptor signaling pathway, which is important for cell growth and differentiation .
Disease Associations

Mutations or dysregulation of the PBLD gene have been associated with certain diseases, including Osebold-Remondini Syndrome . This highlights the importance of PBLD in maintaining normal cellular functions and its potential role in disease mechanisms.

Research and Therapeutic Potential

Recent studies have explored the therapeutic potential of targeting PBLD in various diseases. For instance, research has shown that vitexin, a novel VDR agonist, can regulate macrophage polarization through the VDR/PBLD pathway, thereby mitigating the progression from chronic colitis to colorectal cancer . This indicates that PBLD could be a potential target for therapeutic interventions in inflammatory and cancer-related conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.